SYNKRINO BIOTHERAPEUTICS
Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. The platform is providing monitoring for pediatric rheumatologists for life-threatening conditions. It is currently building a rapid, portable field test for the RNA virus 2019-nCoV/COVID-19, adapting its existing analytic protocols for community public health screening. Synkrino Biotherapeutics' therapeutics use AI + Immunology Discovery Engine (AIDE Engine) which applies neural networks and machine learning to measure the immune tissue from patients to repeatably discover novel and biologically-valid drug targets, enabling healthcare providers to cure their patients and improve their lives.
SYNKRINO BIOTHERAPEUTICS
Industry:
Artificial Intelligence (AI) Biotechnology Health Care Therapeutics
Founded:
2018-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.synkrino.bio
Total Employee:
1+
Status:
Active
Technology used in webpage:
Amazon Google Apps For Business Cloudflare DNS AWS Global Accelerator Webflow
Similar Organizations
ActiveO
ActiveO, a spine technology company, develops and delivers image-guided therapies to treat back pain.
IBIS Therapeutics
IBIS Therapeutics is accelerating drug discovery through Molecular Fingerprintโข Platform
N.A. Genomics
N.A. Genomics is a Personal Health AI Platform that helps to optimize health based on DNA information and other characteristics.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
TransAxon
Reality-level Brain Computer Interfaces
Current Employees Featured
Founder
Investors List
Endpoint Ventures
Endpoint Ventures investment in Seed Round - Synkrino Biotherapeutics
Y Combinator
Y Combinator investment in Seed Round - Synkrino Biotherapeutics
Official Site Inspections
http://www.synkrino.bio
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108

More informations about "Synkrino Biotherapeutics"
Synkrino Biotherapeutics - Crunchbase Company Profile & Funding
Synkrino Biotherapeutics' therapeutics use AI + Immunology Discovery Engine (AIDE Engine) which applies neural networks and machine learning to measure the immune tissue from patients to repeatably discover novel and biologically-valid drug targets, enabling healthcare providers โฆSee details»
Synkrino Biotherapeutics - PitchBook
Www.synkrino.bio. Ownership Status. Out of Business. Financing Status. Formerly VC-backed. Corporate Office. 1111 Broadway; Oakland, CA 94607; United States; Primary Industry. ... Synkrino Biotherapeuticsโs primary industry โฆSee details»
Synkrino Biotherapeutics - Y Combinator
Synkrino's AI, SATIS is a powerful, unbiased discovery system forโฆ. Founded in by Jason Barbour and David Ott, Synkrino Biotherapeutics has 2 employees based in Oakland, CA, USA.See details»
Synkrino Biotherapeutics - VentureRadar
Synkrino Bio's AIDE Engine discovers and develops novel drug targets directly from the immune system of patients. The AI + Immunology Discovery Engine has identified two novel drug โฆSee details»
Synkrino Biotherapeutics - The Org
Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. The platform is providing monitoring for pediatric โฆSee details»
Synkrino Biotherapeutics, Inc. - Company Profile - Corporation Wiki
Jun 14, 2018 Synkrino Biotherapeutics, Inc. Overview. Synkrino Biotherapeutics, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Thursday, June โฆSee details»
Synkrino Biotherapeutics - LinkedIn
Frank Alzaga-Chaudhry Chief Strategy Officer / Chief Business Officer / CEO - Pharma / BiotechSee details»
Synkrino Biotherapeutics - Funding, Financials, Valuation & Investors
Aug 23, 2018 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 23, โฆSee details»
Synkrino Biotherapeutics Company Profile - Office Locations ...
Synkrino Biotherapeutics has 5 employees at their 1 location. See insights on Synkrino Biotherapeutics including office locations, competitors, revenue, financials, executives, โฆSee details»
Synkrino Biotherapeutics - Golden
Synkrino Biotherapeutics is a biotechnology company that offers a platform that works on discovering and developing novel drug targets from the immune system of patients. Synkrino โฆSee details»
Synkrino Biotherapeutics | Company | Mindmaps
Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. Investors Endpoint VenturesSee details»
Synkrino Biotherapeutics - Updates, News, Events, Signals & Triggers
Aug 23, 2018 Organization. Synkrino Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Recent News & Activity. โฆSee details»
Synkrino Biotherapeutics - Products, Competitors, Financials, โฆ
Synkrino Biotherapeutics is a precision medicine analytics platform providing monitoring for pediatric rheumatologists for life-threatening conditions. Synkrino Biotherapeutics is currently โฆSee details»
Synkrino Biotherapeutics - Berkeley Emeryville BIO
Synkrino Biotherapeutics. C/O Citris Foun, UC Berkeley 450 Sutardja Dai Hall. Berkeley. Website. Developer of novel therapeutics designed to treat patients with diseases driven by the immune โฆSee details»
Synkrino Biotherapeutics - Company Information | YCDB - The Y ...
Synkrino Biotherapeutics. Synkrino Bio's AIDE Engine discovers and develops novel drug targets directly from the immune system... Live. Statistics. Compare to all YC; Compare to S18; โฆSee details»
Value Proposition - SDC
Synkrino Development Company partners with biotech to finance and develop innovative high impact therapeutics programs. We serve the entire pharma ecosystem of patients, prescribers, โฆSee details»
Synkrino Biotherapeutics | CipherBio
Explore Synkrino Biotherapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Synkrino Biotherapeutics - Contacts, Employees, Board Members, โฆ
Organization. Synkrino Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. โฆSee details»
David Ott - Synkrino Biotherapeutics - LinkedIn
David and I developed Synkrino Bio in early 2018, working from offices in the Berkeley School of Engineering, before joining Y Combinator that summer.See details»
Top Synkrino Biotherapeutics Competitors and Alternatives - Craft
Synkrino Biotherapeutics's main competitors include Nucleai, Intelligencia, Formation Bio and Biosortia Microbiomics. Compare Synkrino Biotherapeutics to its competitors by revenue, โฆSee details»